talvey
janssen-cilag international n.v. - talquetamab - myeloma multiplex - daganatellenes szerek - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
rosuvastatin sandoz 10 mg filmtabletta
sandoz hungária kft. - rosuvastatin -
rosuvastatin sandoz 20 mg filmtabletta
sandoz hungária kft. - rosuvastatin -
rosuvastatin sandoz 40 mg filmtabletta
sandoz hungária kft. - rosuvastatin -
rosuvastatin sandoz 5 mg filmtabletta
sandoz hungária kft. - rosuvastatin -
dobutamin hameln 5 mg/ml oldatos infúzió
hameln pharma gmbh - dobutamin -
dobutamin hameln 12,5 mg/ml koncentrátum oldatos infúzióhoz
hameln pharma gmbh - dobutamin -
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - sertés - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
mycophenolate mofetil actavis 500 mg filmtabletta
actavis group ptc ehf. - mikofenolát mofetil -
mycophenolate mofetil actavis 250 mg kemény kapszula
actavis group ptc ehf. - mikofenolát mofetil -